rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    TMDX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      TransMedics: 2027 Setting Up To Be A Pivotal Year
      Nov 11Seeking AlphaTMDX
      TransMedics Stock: Growth Is Accelerating Again And 2027 Looks Promising (NASDAQ:TMDX)

      TransMedics Group Inc. demonstrates accelerating revenue growth, improved service margins and market share gains. Read why TMDX stock is a buy.

      Nov 10Seeking AlphaTMDX
      TransMedics: 3 Key Takeaways for Long-Term Investors
      Nov 10Yahoo FinanceTMDX
      Some Experts Think TransMedics Group (TMDX) Has a Near-Monopoly on Keeping Donor Organs Alive
      Nov 7Yahoo FinanceTMDX
      TransMedics Group Q3 Earnings Call Highlights
      Nov 6Yahoo FinanceTMDX
      TransMedics stock rallies on “solid Q3 print” (TMDX:NASDAQ)

      TransMedics (TMDX) stock surges as the company reports better-than-expected financials for Q3 and raises its 2026 outlook. Read more here.

      Nov 6Seeking AlphaTMDX
      Moderna, JFrog, TransMedics, Ubiquiti And Other Big Stocks Moving Higher On Friday
      Nov 6BenzingaFROGMRNATMDXUI
      TransMedics Stock Gains Attention After Revenue Guidance Raise

      TransMedics Group reported third quarter 2026 revenue of US$203.01 million and net income of US$17.07 million. The company raised full year revenue guidance, citing record case volumes and broader use of its organ care and logistics platform. The business increased revenue while industry donor volumes declined, suggesting TransMedics Group is capturing a larger share of organ procedures through its Liver and Heart offerings and its expanding logistics network. We will examine how TransMedics...

      Nov 6Yahoo FinanceTMDX
      Big Q3 earnings beat from BIC pick TransMedics Group (TMDX) | Barron's Investor Circle Community

      TransMedics (TMDX) stock is up 20% in early trading after reporting exceptional Q3 earnings on November 6.

      Nov 6Barron'sTMDX
      Why is TransMedics stock surging today?
      Nov 6Investing.comTMDX
      Canaccord raises TransMedics stock price target on strong Q3 results
      Nov 6Investing.comTMDX
      TransMedics (TMDX) Q3 2026 Earnings Call Transcript

      Motley Fool Press Release.

      Nov 6The Globe and MailTMDX
      TransMedics (TMDX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
      Nov 6Yahoo FinanceTMDX
      TransMedics earnings beat by $0.21, revenue topped estimates
      Nov 5Investing.comTMDX
      TransMedics: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceTMDX
      12 Health Care Stocks Moving In Thursday's After-Market Session
      Nov 5BenzingaTMDX
      Reasons to Retain TransMedics Stock in Your Portfolio for Now
      Nov 4Yahoo FinanceTMDX
      TransMedics to Present at Upcoming Investor Conferences

      TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in three upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the Stifel 2026 Healthcare Conference in New York on Tuesday, November 10, 2026, at 10:40 a.m. EST, the Jefferies Global Healthcare Conference in

      Oct 29Yahoo FinanceTMDX
      TransMedics selects Gogo connectivity for organ transport fleet
      Oct 27Investing.comGOGOTMDX
      TransMedics selects Gogo Galileo HDX for nationwide organ transport fleet

      Reliable, high-performance connectivity will support time-critical transport and monitoring of donor organs for transplants aboard 22 Embraer Phenom 300E aircraftBROOMFIELD, Colo., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Gogo (NASDAQ: GOGO) today announced that TransMedics, the global leader in organ transplantation technology, services and logistics, has selected Gogo Galileo to equip its growing fleet of 22 Embraer Phenom 300E aircraft operating across the United States. The aircraft play a critical

      Oct 27Yahoo FinanceGOGOTMDX
      TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026
      Oct 22Yahoo FinanceTMDX
      TransMedics Group - Some Hiccups In The Long Term Growth Story (NASDAQ:TMDX)

      About two years ago I called TransMedics Group (TMDX) an interesting stock, but not for those with the faint-hearted.

      Oct 18Seeking AlphaTMDX
      TransMedics stock held at Hold by Stifel on competition concerns
      Oct 15Investing.comTMDXSF
      Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)

      Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

      Oct 3The Globe and MailTARSTMDX
      TransMedics Group (TMDX) Stock Looks Below Fair Value On Earnings

      TransMedics Group has seen its share price slide in recent months after a strong multi‑year run, which raises an obvious question for you as an investor. Is the current US$78.64 price still aligned with what the company is earning today, or has sentiment moved ahead of the underlying profit story? Over the past 5 years the stock has gained about 157.4%, which puts real weight on whether the earnings profile can support where the valuation now sits. The business relies on turning highly...

      Oct 2Yahoo FinanceTMDX
      TransMedics Group (TMDX) Could Be 19% Undervalued If Its Growth Narrative Holds
      Oct 2Yahoo FinanceTMDX
      TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too? | The Motley Fool

      Weill's acquisition increased his direct holdings to 16,392 shares, valued at $1.4 million at recent market prices, amid a 30% decline in the stock over the past year.

      Sep 29The Motley FoolTMDX
      TransMedics Offers Attractive Entry Point, With Upside Potential Outweighing Risks (TMDX)

      TransMedics is a market-changing player in organ transplant technology, with a unique multi-organ perfusion platform. Read more on TMDX stock here.

      Sep 26Seeking AlphaTMDX
      Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX)

      Detailed price information for Transmedics Group Inc (TMDX-Q) from The Globe and Mail including charting and trades.

      Sep 23The Globe and MailDBVTTMDX
      TransMedics Stock: Waiting On 2027 Catalysts (NASDAQ:TMDX)
      Sep 18Seeking AlphaTMDX
      2 Stocks Down 28% and 34% to Buy and Hold | The Motley Fool

      These companies' sell-offs may have gone too far.

      Sep 15The Motley FoolSOFITMDX
      TransMedics at 2026 Global Healthcare Conference: growth plan widens
      Sep 15Investing.comTMDX
      TransMedics Group, Inc. (TMDX) Presents at 2026 Global Healthcare Conference - Slideshow
      Sep 15Seeking AlphaTMDX
      TransMedics at Morgan Stanley conference: growth plan turns on logistics
      Sep 14Investing.comTMDXMS
      Canaccord Genuity Keeps Their Buy Rating on TransMedics Group (TMDX)

      Detailed price information for Transmedics Group Inc (TMDX-Q) from The Globe and Mail including charting and trades.

      Sep 12The Globe and MailTMDX
      Needham reiterates Buy on TransMedics stock, names new CFO
      Sep 11Investing.comTMDX
      TransMedics names Fernando Araujo as CFO, reaffirms 2026 outlook
      Sep 10Investing.comTMDX
      TransMedics Names Fernando Araujo as CFO; Maintains 2026 Revenue Outlook
      Sep 10Yahoo FinanceTMDX
      TransMedics: Slowing Growth Brings Its Valuation Into Question (NASDAQ:TMDX)
      Sep 8Seeking AlphaTMDX
      TransMedics: Up 40% Since My Strong Buy Rating. Now What? (NASDAQ:TMDX)
      Sep 5Seeking AlphaTMDX
      Is TMDX Stock Worth Buying as Growth Meets Rising Margin Pressure?
      Sep 3Yahoo FinanceTMDX
      Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?

      TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Sep 3Yahoo FinanceTMDX
      TransMedics to Present at Upcoming September Investor Conferences

      TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference in New York on Monday, September 14, 2026, at 3:20 p.m. EST and at the Baird 2026 Global

      Aug 31Yahoo FinanceTMDX
      TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX
      Aug 29MorningstarTMDX
      Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
      Aug 25MorningstarTMDX
      Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and NeoGenomics (NEO)

      Detailed price information for Neogenomics Inc (NEO-Q) from The Globe and Mail including charting and trades.

      Aug 25The Globe and MailNEOTMDX

      This is the newest page. Registered accounts read further back.